Literature DB >> 28757275

Protective effects of sinomenine against LPS-induced inflammation in piglets.

Haifeng Yang1, Chunmao Jiang1, Xiaolan Chen1, Kongwang He2, Yiyi Hu3.   

Abstract

The aim of this study was to investigate in piglets, the anti-endotoxin and anti-inflammatory effects of sinomenine, an agent commonly found in Chinese herbal medicines. In high-, middle- and low-dose sinomenine groups, piglets were initially challenged with endotoxin (i.e., 1 mg lipopolysaccharide (LPS)/kg) by intraperitoneal (IP) injection and, 3 h later, intramuscularly (IM) with sinomenine at 1, 5, or 10 mg/kg. In a drug control group, piglets were dosed IP with vehicle and 3 h late IM with 10 mg/kg sinomenine while those in an LPS control group were challenged with 1 mg LPS/kg (IP) and then vehicle 3 h later; naïve control piglets were administered normal saline IP and then IM only. At 12, 24, and 48 h post-LPS/vehicle injection, blood samples were collected from the precaval vein of piglets. Clinical signs were recorded during the trial and index levels were analyzed by ELISA kits. The results revealed sinomenine could reduce the incidence/severity of certain LPS-induced toxicities, e.g., cell adhesion, systemic inflammation, and multiple organ dysfunction. Taken together, the data suggested to us that sinomenine might effectively be useful to regulate inflammatory responses as part of future anti-endotoxin therapies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endotoxin; Inflammation; LPS; Sinomenine

Mesh:

Substances:

Year:  2017        PMID: 28757275     DOI: 10.1016/j.micpath.2017.07.044

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Sex-related differences in safety profiles, pharmacokinetics and tissue distribution of sinomenine hydrochloride in rats.

Authors:  Hong Huang; Er-Bing Zhang; Ou-Yang Yi; Han Wu; Guiming Deng; Yu-Ming Huang; Wen-Liang Liu; Jian-Ye Yan; Xiong Cai
Journal:  Arch Toxicol       Date:  2022-08-30       Impact factor: 6.168

2.  Cardioprotective effects of sinomenine in myocardial ischemia/reperfusion injury in a rat model.

Authors:  Changhong Lu; Xiao Guo; Xianghui He; Yu Chang; Fa Zheng; Chenji Xu; Shuwen Zhang; Yaqun Zhou; Junfang Li
Journal:  Saudi Pharm J       Date:  2022-04-21       Impact factor: 4.562

3.  Sinomenine attenuates cancer-induced bone pain via suppressing microglial JAK2/STAT3 and neuronal CAMKII/CREB cascades in rat models.

Authors:  Shu-Ping Chen; Jia Sun; Ya-Qun Zhou; Fei Cao; Cody Braun; Fang Luo; Da-Wei Ye; Yu-Ke Tian
Journal:  Mol Pain       Date:  2018-07-20       Impact factor: 3.395

4.  Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway.

Authors:  ManLi Yuan; Bei Zhao; Huaping Jia; Can Zhang; Xiaowen Zuo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Pseudorabies Virus: From Pathogenesis to Prevention Strategies.

Authors:  Hui-Hua Zheng; Peng-Fei Fu; Hong-Ying Chen; Zhen-Ya Wang
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

6.  Sinomenine reduces neuronal cell apoptosis in mice after traumatic brain injury via its effect on mitochondrial pathway.

Authors:  Chuanjing Fu; Xiaofu Zhai; Qi Wang; Juemin Gao
Journal:  Drug Des Devel Ther       Date:  2018-01-05       Impact factor: 4.162

7.  Serum proteomic analysis of the anti‑arthritic effects of sinomenine on rats with collagen‑induced arthritis.

Authors:  Xin Qian; Zhiming Zhao; Wei Shang; Zhihan Xu; Beibei Zhang; Hui Cai
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.